Reference
·Supporting source
Bangkok aesthetic medical-tourism revenue (2027 path)
USD 1.4-2.6B
Bangkok aesthetic medical-tourism revenue is on track to reach USD 1.4-2.6B by 2027, up from USD 380-680M in 2024, anchored by hair transplant FUE/DHI, scalp PRP, beard and eyebrow restoration, and aesthetic adjacencies (botox, filler, ultrasound thread-lift, exosome). TAT medical-tourism arrival statistics, BOI Section 8 incentive uptake, and SCB EIC aesthetic outlook frame the trajectory; ISHRS practice census triangulates global hair-restoration benchmarks. The growth driver stack combines cost arbitrage vs Turkey/Korea/USA, Korean-medical-tourism-fatigue, LTR retiree demand, and Bumrungrad/BDMS aesthetic cross-sell.
Figure in context
Bangkok aesthetic medical-tourism revenue is on track to reach USD 1.4-2.6B by 2027, up from USD 380-680M in 2024, anchored by hair transplant FUE/DHI, scalp PRP, beard and eyebrow restoration, and aesthetic adjacencies (botox, filler, ultrasound thread-lift, exosome). TAT medical-tourism arrival statistics, BOI Section 8 incentive uptake, and SCB EIC aesthetic outlook frame the trajectory; ISHRS practice census triangulates global hair-restoration benchmarks. The growth driver stack combines cost arbitrage vs Turkey/Korea/USA, Korean-medical-tourism-fatigue, LTR retiree demand, and Bumrungrad/BDMS aesthetic cross-sell.
Bangkok aesthetic medical-tourism revenue is on track to reach USD 1.4-2.6B by 2027, up from USD 380-680M in 2024, anchored by hair transplant FUE/DHI, scalp PRP, beard and eyebrow restoration, and aesthetic adjacencies (botox, filler, ultrasound thread-lift, exosome). TAT medical-tourism arrival statistics, BOI Section 8 incentive uptake, and SCB EIC aesthetic outlook frame the trajectory; ISHRS practice census triangulates global hair-restoration benchmarks. The growth driver stack combines cost arbitrage vs Turkey/Korea/USA, Korean-medical-tourism-fatigue, LTR retiree demand, and Bumrungrad/BDMS aesthetic cross-sell.
Time scope
2027 forecast vs FY2024 baseline
Source basis
Supporting source
Interpretation notes
What this tells you
Bangkok aesthetic medical-tourism revenue is on track to reach USD 1.4-2.6B by 2027, up from USD 380-680M in 2024, anchored by hair transplant FUE/DHI, scalp PRP, beard and eyebrow restoration, and aesthetic adjacencies (botox, filler, ultrasound thread-lift, exosome). TAT medical-tourism arrival statistics, BOI Section 8 incentive uptake, and SCB EIC aesthetic outlook frame the trajectory; ISHRS practice census triangulates global hair-restoration benchmarks. The growth driver stack combines cost arbitrage vs Turkey/Korea/USA, Korean-medical-tourism-fatigue, LTR retiree demand, and Bumrungrad/BDMS aesthetic cross-sell.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thai FUE per-graft ASP envelope (THB, 2027)
Absolute Hair Clinic price list, Hairsmith Clinic pricing, Forhair Bangkok pricing, ISHRS regional benchmarks
Thai aesthetic medical-tourism arrivals (2027 path)
Tourism Authority of Thailand, Korea Tourism Organisation outbound, Thailand LTR visa statistics
Bangkok FUE 2,500-5,500 graft session price (THB)
Absolute Hair Clinic packages, Hairsmith Clinic packages, Asia Cosmetic Hospital pricing, Forhair Bangkok pricing
Bangkok aesthetic-adjacent (botox, filler, thread, PRP) revenue 2027
SCB EIC aesthetic outlook, BAAC service catalogue, Nirunda price list, Apex Profound Beauty pricing
Top-8 Bangkok hair-restoration operator share of disclosed capacity
Operator websites, Healthcare Accreditation Institute, MoPH HSS licensing data
Thailand LTR wealthy-pensioner aesthetic adoption rate (2027)
Thailand BOI LTR statistics, Bumrungrad investor disclosures, BDMS aesthetic service-line data
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.